ProQR(PRQR) - 2025 Q4 - Annual Report

Exhibit 99.1 ProQR Announces Year End 2025 Operating and Financial Results LEIDEN, Netherlands & CAMBRIDGE, Mass., March 12, 2026 – ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today reported its financial and operating results for the year ended December 31, 2025, and provided a business update. "2025 was a year of meaningful clinical progress for ProQR as we adva ...